not true. According to PhRMA (“the process behind new medicines”, 2015, online) , average clinical development time (from phases1 to 3) is around 6-7 years. Total time discovery to approval 10 years. So you’re well off the mark sorry. But I guess phrma data based on companies that know what they’re doing and are actually doing stuff. 15-20 years is probably about right when you have a company that’s a scientist’s hobby with job for life md.
Ann: BIT225 HIV-1 Immunomodulatory Paper Published, page-37
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
